Biotech

All Articles

Orion to make use of Aitia's 'electronic identical twins' to locate brand new cancer drugs

.Finnish biotech Orion has snooped possible in Aitia's "digital twin" tech to develop new cancer cel...

Windtree's surprise med rears high blood pressure in latest period 2 gain

.While Windtree Therapeutics has strained to develop the economic origins needed to have to endure, ...

2 cancer biotechs merge, making global footprint

.OncoC4 is taking AcroImmune-- and its in-house professional production capacities-- under its wing ...

Amgen documents 1st stage 3 win for $400M dermatitis medication

.Amgen has actually shared (PDF) the first phase 3 records on its own $400 million chronic eczema me...

Biogen, UCB record phase 3 lupus gain after neglecting earlier test

.Biogen and UCB's bank on advancing right into period 3 astride a failed research study looks to hav...

Aptadir hopes new RNA preventions can reverse challenging cancers cells

.Italian biotech Aptadir Rehabs has actually launched along with the promise that its pipeline of pr...

Wave surfs DMD effectiveness to regulatory authorities' doors, delivering stockpile

.Surge Lifestyle Sciences has met its goal in a Duchenne muscular dystrophy (DMD) research, installi...

Sanofi picks brand-new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, taking up the l...

Achilles drops cell therapy system, braces for layoffs after skipping 'commercial stability' objectives

.Achilles Therapeutics has shreded its own approach. The British biotech is actually quiting working...

Aligos heralds stage 2 MASH succeed, reducing liver excess fat up to 46%

.Aligos Rehabs is actually declaring a midstage succeed in metabolic-dysfunction associated steatohe...